Daytrading April 2 Morning, page-7

PAA excellent Ann yesterday. Huge upside targeting the $42bill chemotherapy industry. Their main drug has demonstrated safety in humans as well as large reductions in tumour markers.
Once the investment community gets wind of the fact that they potentially have an efficacious, safe drug, with no toxicity, which can be administered orally, this company will be worth $100m